TGF-beta1 and endothelial/tissue injury with high-dose intravenous iron therapy in renal failure: evidence or perception?

Clin Appl Thromb Hemost. 2006 Oct;12(4):493-4. doi: 10.1177/1076029606293837.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiopathology
  • Humans
  • Infusions, Intravenous
  • Iron / administration & dosage*
  • Iron / adverse effects
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / drug therapy*
  • Transforming Growth Factor beta / blood
  • Transforming Growth Factor beta / physiology*
  • Transforming Growth Factor beta1

Substances

  • TGFB1 protein, human
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • Iron